Latest News: Health insights
CanSinoBIO’s mRNA Covid Vaccine Cleared For Trials in China
Monday April 4, 2022
Chinese vaccine developer CanSino Biologics said on Monday its potential Covid-19 vaccine using mRNA technology has been approved by the medical products regulator to enter clinical trials
Notice: Undefined variable: args in /var/www/asiafinancialcom/wp-content/themes/atf/category.php on line 1867
« Previous 1 … 6 7 8
ABOUT AF
RESOURCES
LEGAL + PRIVACY
DISCLAIMER
Asia Financial is owned by Capital Link International Holdings Ltd, 902, Wilson House 19-27 Wyndham Street, Central, Hong Kong. www.capitallinkintl.com
